Drug & Therapeutics Subcommittee



Subscribe to posts

D&T Subcommittee Meeting Bil. 04/2020

posted Dec 22, 2020, 5:49 PM by Ho Ai Wui   [ updated Jan 20, 2021, 12:58 AM by Rafidah binti Abd Rahim ]

No

Drug Name

Decision

1

Apalutamide 60mg Tablet (Erleada)

Rejected as Special Formulary

2

Azelastine/Fluticasone Propionate 137mcg/50mcg Nasal Spray (Dymista)

Rejected as Special Formulary.

Available mometasone, flixonase nasal spray and oral antihistamine in standard formulary

3

Baricitinib 2mg Tablet (Olumiant)

Accepted as Special Formulary.

Order upon request

4

Baricitinib 4mg Tablet (Olumiant)

Accepted as Special Formulary.

Order upon request

5

Beclomethasone 100mcg Formoterol 6mcg (Foster NEXThaler)

Rejected as Special Formulary

6

Bevacizumab 400mg Injection (MVASI)

Accepted as Standard Formulary.

MVASI for Clinical Oncologist. 
Maintain AVASTIN for Ophthalmologist

7

Bilastine 20mg Tablet (Bilaxten)

Rejected as Special Formulary

8

Bilastine 20mg Tablet (Bilaxten)

Rejected as Special Formulary. Available cetirizine and loratadine ( 2nd generation antihistamines) in the standard formulary.

9

Brexpiprazole 1mg Tablet (REXULTI)

Rejected as Special Formulary

10

Brexpiprazole 2mg Tablet (REXULTI)

Rejected as Special Formulary

11

Brexpiprazole 3mg Tablet (REXULTI)

Rejected as Special Formulary

12

Brexpiprazole 4mg Tablet (REXULTI)

Rejected as Special Formulary

13

Dacomitinib 15mg Tablet (Vizimpro)

Rejected as Special Formulary

14

Desmopressin Oral Lyophilisates 60mcg Sublingual Tablet (Minirin Melt)

Rejected as Standard Formulary

Will replace Desmopressin 100mcg Tablet & Desmopressin 100mcg/mL nasal spray as Special Formulary instead.

 

15

Desmopressin Oral Lyophilisates 120mcg Sublingual Tablet (Minirin Melt)

Rejected as Standard Formulary

Will replace Desmopressin 200mcg Tablet as Special Formulary instead.

 

16

Diltiazem 100mg sustained release   capsule (Herbesser R100)

Agreed to add Nephrologist as prescriber

17

Diltiazem 200mg sustained release   capsule (Herbesser R200)

Agreed to add Nephrologist as prescriber

18

Duosol™ Bicarbonate Dialysate

Agreed to accept as Special Formulary.

Purchase upon request.
Prescriber: Nephrologist, Anesthesiologis
Indication: as dialysis solution for patient with high serum lactate and not suitable in using PrismaSol® Solution.

19

Empagliflozin 10mg Tab (Jardiance)

Agreed to include gastroenterologist as prescriber in Special Formulary.

20

Goserelin 10.8mg Depot Injection (Zoladex LA)

Rejected as Special Formulary

21

Goserelin 3.6mg Injection (Zoladex)

Rejected as Special Formulary (to replace leuprorelin 11.25mg 3 monthly)

22

Menotrophin 75units Injection (Menopur)

Request as Special Formulary

23

Scopolamine 1.5mg Transdermal patch (Ariel TDDS)

Agreed to accept as Special Formulary

24

Selexipag 1000mcg Tablet (Uptravi)

Rejected as Special Formulary

25

Selexipag 1200mcg Tablet (Uptravi)

Rejected as Special Formulary

26

Selexipag 1400mcg Tablet (Uptravi)

Rejected as Special Formulary

27

Selexipag 1600mcg Tablet (Uptravi)

Rejected as Special Formulary

28

Selexipag 200mcg Tablet (Uptravi)

Rejected as Special Formulary

29

Selexipag 400mcg Tablet (Uptravi)

Rejected as Special Formulary

30

Selexipag 600mcg Tablet (Uptravi)

Rejected as Special Formulary

31

Selexipag 800mcg Tablet (Uptravi)

Rejected as Special Formulary

32

Sofosbuvir 400mg/Velpatasvir 100mg Tablet (MyHepALL)

Agreed to accept as Special Formulary.
To replace sofosbuvir 400mg tab and daclatasvir 60mg tab in UMMC formulary.

33

Tacrolimus 0.5mg Capsule (Prograf)

Agreed to accept as Special Formulary for liver transplant (adults & paeds). All liver transplant patients purchase at full price from PharmUMMC.

34

Tacrolimus 1mg Capsule (Prograf)

Agreed to accept as Special Formulary for liver transplant (adults & paeds). All liver transplant patients purchase at full price from PharmUMMC.

35

Tenofovir Alafenamide 25mg Tab (MyTAFF)

Rejected as Standard Formulary

36

Teriparatide 20mcg per dose Injection
(FORTEO)

Agreed to include new prescriber in  Special Formulary. 

Prescriber: Orthopaedic Surgeon, Geriatrician, Endocrinologist. Indication: Treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture.

Must fulfil all criteria in 'Teriparatide prescribing checklist' and submit together with Borang 1/09 for a government-funded patient. Maximum 2 years treatment per patient.

37

Triptorelin acetate 0.1mg Injection (DECAPEPTYL)

Agreed to accept as Special Formulary. Prescriber: obstetrics and gynaecologist
Indication: treatment for endometriosis & uterine myoma in women and hormone-dependent prostate carcinoma in men

38

Daclatasvir 60mg Tablet
(Daclavir)

Agreed to remove from the UMMC Formulary.

Replaced by Sofosbuvir 400mg/Velpatasvir 100mg Tablet (MyHepALL)

39

Rotigotine 4mg/24 hours

Agreed  to remove from the UMMC Formulary as it is slow moving resulting in expired stock.

Product discontinuation.

 

40

Rotigotine 6mg/24 hours

Request to remove from the UMMC Formulary as it is slow moving resulting in expired stock.

Product discontinuation.

 

41

Salbutamol 2mg/5mL syrup

Agreed to remove from the UMMC Formulary as it is slow moving.

 

42

Sofosbuvir 400mg Tablet
(VIRSO)

Agreed  to remove from the UMMC Formulary. Replaced by Sofosbuvir 400mg/Velpatasvir 100mg Tablet (MyHepALL).

 

43

Tetracycline 250mg Cap

Agreed to remove from the UMMC Formulary as it is slow moving.

 

 

Disclaimer: 

For new drug requests, physical stock availability will depend on procurement processes. 

Tender items will take about 3-6 months, non tender items will take about 1-3 months. 

Online formulary will be updated once physical stock is available or has depleted in UMMC Pharmacy.




D&T Subcommittee Meeting Bil. 03/2020

posted Oct 1, 2020, 12:09 AM by Rafidah binti Abd Rahim   [ updated Dec 22, 2020, 6:00 PM by Ho Ai Wui ]

No.

Drug Name

Decision

1

Apixaban 2.5mg Film Coated Tablet (Eliquis)

Agreed to add Neurologist as prescriber.

2

Apixaban 2.5mg Film Coated Tablet (Eliquis)

Agreed to add Nephrologist as prescriber.

3

Apixaban 5mg Film Coated Tablet (Eliquis)

Agreed to add Neurologist as prescriber.

4

Apixaban 5mg Film Coated Tablet (Eliquis)

Agreed to add Nephrologist as prescriber.

5

Bevacizumab 100mg Injection (MVASI)

Rejected as Special Formulary.

6

Bevacizumab 400mg Injection (MVASI)

Agreed to defer to next D&T meeting.
To get input from Ophthalmology team regarding MVASI use in the treatment of Age-related Macular Degeneration (AMD).

7

Daptomycin 500mg Injection (Cubicin)

Agreed to accept as Standard Formulary.
Limited to 8 patients per year.
Agreed to remove Tigecycline from the UMMC Formulary.

8

Desmopressin 4mcg Injection (Minirin)

Agreed to add Intensive Care Team as prescriber.

9

Dulaglutide 0.75mg Injection
(Trulicity)

Rejected as Special Formulary.

Dulaglutide 1.5mg available in Special Formulary.

10

Dulaglutide 1.5mg Injection
(Trulicity)

Agreed to add Cardiologist & Nephrologist (for patients with eGFR 15-30 only) as prescriber.

11

Erythromycin 500mg Injection

Agreed to accept as Standard Formulary.

12

Evolocumab 140mg Injection (Repatha)

Rejected as Special Formulary.

Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis.

13

Guselkumab 100mg Injection (Tremfya)

Agreed to accept as Special Formulary.

14

Rivaroxaban 2.5mg Tablet (Xarelto)

Rejected to add in new strength with new indication and new prescriber.

Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis.

15

Trastuzumab 600mg/5mL Inj (Herceptin SC)

Rejected as Special Formulary.

Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis.

16

Ustekinumab 130mg/26mL Injection (Stelara)



Rejected as Special Formulary.

Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis.

17

Ustekinumab 90mg/1.0mL Injection (Stelara)

Rejected as Special Formulary.

Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis.

18

Iron Hydroxide Sucrose Complex 100mg/5mL Injection
(Venofer)

Agreed to remove Venofer from the UMMC Formulary.

Agreed to accept Monofer as Special Formulary.

19

Oxymetholone 50mg Tablet

Agreed to remove Oxymetholone 50mg tablet from the UMMC Formulary.

20

Sodium chloride 0.9% Eye Drops

Agreed to remove Sodium Chloride 0.9% Eye Drops from the UMMC Formulary.

21

Tigecycline 50mg Injection (Tygacil)

Agreed to remove Tigecycline from the UMMC Formulary.
Agreed to accept Daptomycin as Standard Formulary.

22

Deferasirox 125mg Dispersible Tablet
(EXJADE)		Rejected from procurement discontinuation.
EXJADE continues as Special Formulary. Pharmacy to monitor stock movement closely to prevent wastage due to expired stock.

23

Iron (III) Isomaltoside 500mg/5mL Injection
(Monofer)

Agreed to accept as Special Formulary.
Agreed to delete Venofer from the UMMC Formulary.


Disclaimer: 

For new drug requests, physical stock availability will depend on procurement processes. 

Tender items will take about 3-6 months, non tender items will take about 1-3 months. 

Online formulary will be updated once physical stock is available or has depleted in UMMC Pharmacy.



D&T Subcommittee Meeting Bil. 02/2020

posted Sep 30, 2020, 8:56 PM by Rafidah binti Abd Rahim   [ updated Sep 30, 2020, 8:59 PM ]

No.

Drug Name

Decision

1

Daclatasvir 60mg Tablet (Daclavir)

Agreed to accept as Standard Formulary. Subsidy for 30 patients per year.

Pharmacy to request for additional funding from JPKA. Temporarily list in as Special Formulary while waiting for approval from JPKA.

2

Denosumab 60mg Injection
(Prolia)		Agreed to accept as Special Formulary.
First line: Alendronic acid.
Consider Denosumab if:
(1) eGFR < 35mL/min OR
(2) Treatment failure with oral bisphosphonates for at least 5 years or iv bisphosphonates for at least 3 years despite compliance.

3

Everolimus 2mg Tablet
(AFINITOR DISPERZ)		Rejected as Special Formulary. 
Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis.

4

Everolimus 3mg Tablet
(AFINITOR DISPERZ)

Rejected as Special Formulary. 
Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis.

5

Everolimus 5mg Tablet
(AFINITOR DISPERZ)

Rejected as Special Formulary. 
Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis.

6

Remifentanyl 1mg Injection
(Ultiva)

Agreed to accept as Special Formulary.

7

Sirolimus 1mg Tablet (Rapamune)

Agreed to add Paediatric Onco - Hematologist and Paediatric Neurologist as prescribers.

Rejected to subsidized all paediatric patients, instead, subsidy for 3 paediatric patients per year only (on yearly rotational basis).

8

Sofosbuvir 400mg Tablet
(VIRSO)

Agreed to accept as Standard Formulary. Subsidy for 30 patients per year.

Pharmacy to request for additional funding from JPKA. Temporarily list in as Special Formulary while waiting for approval from JPKA.

9

Somatropin 6mg Injection
(Saizen Liquid)

Agreed to accept as Special Formulary.

Agreed to remove Somatropin 8mg Injection (Saizen) from the UMMC formulary.

10

Request as Special Formulary, to replace Somatropin 8mg Injection (Saizen).Rejected as Special Formulary.
Agreed to accept Somatropin 6mg Injection (Saizen Liquid) as Special Formulary.

11

Teriparatide 20mcg per dose Injection
(FORTEO)

Agreed to add Geriatrician as prescriber. 

12

Zoledronic Acid 5mg Injection
(Aclasta)

Agreed to add Geriatrician as prescriber. 

13

Dasabuvir 250mg Tablet
(Exviera)

Agreed to remove Dasabuvir 250mg Tablet (Exviera) from the UMMC Formulary.
Agreed to accept VIRSO and Daclavir as Standard Formulary in replace of Dasabuvir 250mg Tablet (Exviera).

14

Ombitasvir 12.5mg Paritaprevir 75mg Ritonavir 50mg Tablet
(Viekirax)		Agreed to remove Ombitasivir 12.5mg Paritaprevir 75mg Ritonavir 50mg Tablet (Viekirax) from the UMMC Formulary.
Accepted VIRSO and Daclavir as Standard Formulary in replace of Viekirax.

15

Paliperidone 3mg Extended-Release Tablet
(Invega)		Agreed to remove Paliperidone 3mg Extended-Release Tablet (Invega) from the UMMC Formulary.

16

Somatropin 8mg Injection
(Saizen)

Agreed to remove Somatropin 8mg Injection (Saizen) from the UMMC Formulary.
Agreed to accept Somatropin 6mg Injection (Saizen Liquid) as Special Formulary in replace of Somatropin 8mg Injection (Saizen).

Disclaimer: 

For new drug requests, physical stock availability will depend on procurement processes. 

Tender items will take about 3-6 months, non tender items will take about 1-3 months. 

Online formulary will be updated once physical stock is available or has depleted in UMMC Pharmacy.



D&T Subcommittee Meeting Bil. 01/2020

posted May 20, 2020, 9:20 PM by Chong Ching Wern   [ updated May 20, 2020, 9:22 PM ]

No.

Drug Name

Decision

1

Anastrozole 1mg Tablet

Agreed to remove Anastrozole 1mg Tablet from Outpatient Pharmacy and maintain Anastrozole as Special Formulary (PharmUMMC Pharmacy only).

Agreed to accept Letrozole 2.5mg Tablet as Standard Formulary (Outpatient Pharmacy only).

2

Apixaban 2.5mg Tablet (Eliquis)

Agreed to add Respiratory Medicine Specialist as prescriber.

3

Apixaban 5 mg Tablet (Eliquis)

Agreed to add Respiratory Medicine Specialist as prescriber.

4

Ciprofloxacin 0.3% Fluocinolone Acetonide 0.025% Ear Drops 

(Cetraxal Plus)

Rejected as Standard Formulary.

Availability of Ofloxacin 0.3% Ear Drop in the UMMC Formulary. Suggest to purchase from retail pharmacies if there is a need to use the combination.

5

Dapagliflozin 10mg Tablet

(Forxiga)

Agreed to add Cardiologist as prescriber.

6

Dupilumab 300mg/2mL Injection

(Dupixent)

Rejected as Special Formulary.

Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis.

7

Erenumab 70mg Injection

(Pasurta)

Rejected as Special Formulary.

Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis.

8

Escitalopram 10mg Tablet

Agreed to add Neurologist as prescriber.

9

Fondaparinux 7.5mg Injection

(Arixtra)

Rejected as Special Formulary.

There is no additional cost benefit compared to Fondaparinux 2.5mg Injection and Enoxaparin Injection.

10

Fusidic Acid 2% Cream

(Fucidin)

Rejected Fusidic Acid 2% Cream as Standard Formulary.

Availability of Mupirocin 2% Ointment in the UMMC Formulary. Suggest to purchase from retail pharmacies if there is a need to use.

Agreed to add Dermatologist as prescriber for Mupirocin 2% Ointment.

11

Glycopyrronium 50mcg Inhalation Powder Hard Capsule

(Seebri Breezhaler)

Agreed to accept as Special Formulary.

12

Human Normal Immunoglobulin 20% (2g/10mL) Solution for Subcutaneous Injection

(Hizentra)

Agreed to accept as Standard Formulary.

Use is limited to five patients a year.

13

Iron (III) Isomaltoside 500mg/5mL Injection

(Monofer)

Agreed to accept Iron (III) Isomaltoside 500mg/5mL Injection

(Monofer) as Special Formulary.

Agreed to remove Iron Hydroxide Sucrose Complex 100mg/5mL Injection (Venofer) from the UMMC formulary.

14

Ixekizumab 80mg Pre-filled Pen Injection

(Taltz)

Rejected as Special Formulary.

Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis.

15

Letrozole 2.5mg Tablet

(Femara)

Agreed to accept Letrozole 2.5mg Tablet as Standard Formulary (Outpatient Pharmacy only).

Agreed to remove Anastrozole 1mg Tablet from Outpatient Pharmacy and maintain Anastrozole 1mg Tablet as Special Formulary (PharmUMMC Pharmacy only).

16

Menotrophin 600units Injection

(Menopur Multidose)

Agreed to accept Menotrophin 600units Injection (Menopur Multidose) as Special Formulary.

Agreed to remove Menotrophin 75units Injection from the UMMC Formulary.

17

Mometasone Furoate Monohydrate 50mcg Nasal Spray

(Momate)

Agreed to accept Mometasone Furoate Monohydrate 50mcg Nasal Spray(Momate) as Standard Formulary.

Agreed to remove Budesonide 64mcg Nasal Spray from the UMMC Formulary.

18

Montelukast 10mg Tablet

Rejected to add Primary Care Specialist as prescriber, to maintain current restriction.

Primary Care Specialists are allowed to continue maintenance treatment initiated by Respiratory Medicine Specialists.

19

Mupirocin 2% Ointment

Agreed to add Dermatologist as prescriber.

20

Salmeterol 25mcg Fluticasone 125mcg Inhaler

Rejected to add Primary Care Specialist as prescriber, to maintain current restriction.

Primary Care Specialists are allowed to continue maintenance treatment initiated by Respiratory Medicine Specialists.

21

Salmeterol 25mcg Fluticasone 250mcg Inhaler

Rejected to add Primary Care Specialist as prescriber, to maintain current restriction.

Primary Care Specialists are allowed to continue maintenance treatment initiated by Respiratory Medicine Specialists.

22

Sirolimus 1mg Tablet

(Rapamune)

To be discussed again in the following D&T Meeting.

23

Venlafaxine 150mg XR Capsule

(Effexor XR)

Agreed to add Neurologist as prescriber.

24

Venlafaxine 37.5mg XR Capsule

(Effexor XR)

Agreed to add Neurologist as prescriber.

25

Venlafaxine 75mg XR Capsule

(Effexor XR)

Agreed to add Neurologist as prescriber.

26

Zonisamide 100mg Tablet

(Zonegran)

Agreed to accept as Standard Formulary.

27

Budesonide 64mcg Nasal Spray

Agreed to remove Budesonide 64mcg Nasal Spray from the UMMC Formulary.

Agreed to accept Mometasone Furoate Monohydrate 50mcg Nasal Spray(Momate) as Standard Formulary.

28

Iron Hydroxide Sucrose Complex 100mg/5mL Injection

(Venofer)

Agreed to remove Iron Hydroxide Sucrose Complex 100mg/5mL Injection (Venofer) from the UMMC formulary.

Agreed to accept Iron (III) Isomaltoside 500mg/5mL Injection

(Monofer) as Special Formulary.

29

Menotrophin 75units Injection

Agreed to remove Menotrophin 75units Injection from the UMMC Formulary.

Agreed to accept Menotrophin 600units Injection (Menopur Multidose) as Special Formulary.


Disclaimer: 

For new drug requests, physical stock availability will depend on procurement processes. 

Tender items will take about 3-6 months, non tender items will take about 1-3 months. 

Online formulary will be updated once physical stock is available or has depleted in UMMC Pharmacy.

D&T Subcommittee Meeting Bil. 03/2019

posted Oct 17, 2019, 8:31 PM by Chong Ching Wern   [ updated Oct 17, 2019, 11:56 PM ]

No.

Drug Name

Decision

1)

Amoxycillin 1000mg Tablet

(Ospamox)

Agreed to restore as Special Formulary. Pharmacy to monitor one year usage.

2)

Dabigatran 110mg Capsule

(Pradaxa)

Agreed to add Neurologist as prescriber.

3)

Dabigatran 150mg Capsule

(Pradaxa)

Agreed to add Neurologist as prescriber.

4)

Dabigatran 75mg Capsule

(Pradaxa)

Agreed to add Neurologist as prescriber.

5)

Dulaglutide 1.5mg Injection

(Trulicity)

Agreed to accept Dulaglutide 1.5mg Injection

(Trulicity) as Special Formulary.


Agreed to delete Exenatide 2mg Injection (Bydureon) from the UMMC's formulary.

6)

EDTA 2% Eye Drops

Agreed to accept as Standard Formulary.

7)

Flecainide 100mg Tablet

(Tambocor)

Agreed to accept as Special Formulary.

8)

Insulin Degludec 70% Aspart 30% 300units/3mL Pen Injection

(Ryzodeg FlexTouch)

Rejected as Special Formulary.

Costs more than existing agents available in the UMMC's Formulary.

Available in UMSC for purchase and slow moving in UMSC.

9)

Levamisole 50mg Tablet

Agreed to accept as Standard Formulary.

10)

Mirabegron 25mg Prolonged-Release Tablet

(Betmiga)

Rejected as Standard Formulary, to maintain current status as Special Formulary.

11)

Mirabegron 50mg Prolonged-Release Tablet

(Betmiga)

Rejected as Standard Formulary, to maintain current status as Special Formulary.

12)

Quadrivalent Influenza Vaccine Injection, Split Virion, Inactivated

(VaxigripTetra)

Rejected to add Infectious Disease Specialist as prescriber, to maintain current restriction.


However, D&T Committee to propose to higher management for free annual vaccination for UMMC front liners as per Ministry of Health's indication.

13)

Saccharomyces boulardii CNCM I-745 250mg Capsule

(Bioflor)

Agreed to accept as Special Formulary in PharmSelatan.

Non-claimable.

14)

Saccharomyces boulardii CNCM I-745 250mg Powder for Oral Suspension

(Bioflor)

Agreed to accept as Special Formulary in PharmSelatan.

Non-claimable.

15)

Zonisamide 100mg Tablet

(Zonegran)

To invite Neurologist to the next D&T Meeting.

Suggest to remove one item to replace Zonisamide in Standard Formulary.

16)

Exenatide 2mg Injection

(Bydureon)

Agreed to delete Exenatide 2mg Injection (Bydureon) from the UMMC's formulary.

Reason: Accepted Dulaglutide 1.5mg Injection (Trulicity) as Special Formulary in D&T Bil. 03/2019.

17)

Propafenone 150mg Tablet

(Rytmonorm)

Agreed to delete from the UMMC's formulary.

Company discontinued distribution.

18)

Human Albumin 20% Injection Guideline

Agreed to accept proposed guideline.

19)

New Drug Request Form / SOP Modification

Agreed to proceed to propose to higher management for approval.


Disclaimer: 

For new drug request, physical stock availability will depend on procurement processes. 

Tender items will take about 3-6 months, non tender items will take about 1-3 months. 

Online formulary will be updated once physical stock is available or has depleted in UMMC Pharmacy.

D&T Subcommittee Meeting Bil. 02/2019

posted Jul 1, 2019, 6:06 PM by Chong Ching Wern   [ updated Jul 1, 2019, 6:16 PM ]


No.

Drug Name

Decision

1)

Propafenone 150mg Tablet

(Rytmonorm)

Agreed to accept as Special Formulary.

2)

Flecainide 100mg Tablet

(Tambocor)

Rejected as Special Formulary.

Propafenone was accepted as Special Formulary for the same indication.

3)

Deferasirox 90mg Tablet

Deferasirox 360mg Tablet

(Exjade)

Rejected as Standard Formulary.

Suggest requestor to apply for extra funding from Jawatankuasa Pengurusan Kewangan dan Akaun (JPKA) for additional subsidy for five patients.

4)

Flurbiprofen 4mg Patch

(Acustop Cataplasma)

Rejected as Special Formulary.

Availability of Diclofenac Gel and Ketoprofen Gel in the UMMC formulary and readily available in retail pharmacies.

5)

Paroxetine 25mg CR Tablet

(Seroxat)

Agree to delete from the UMMC formulary.

To use generic option as first choice and was agreed by Psychiatric Team to switch to Apo-Paroxetine 20mg Tablet.

6)

Montelukast 4mg Tablet

(Singulair)

Agree to delete from the UMMC formulary.

Slow movement and stocks were expired. Availability of Montelukast 4mg Granules in the UMMC formulary.

7)

Telbivudine 600mg Tablet

(Sebivo)

Agree to delete from the UMMC formulary.

Company discontinuation.

8)

Tinzaparin 4500units Injection

(Innohep)

Agree to delete from the UMMC formulary.

Company discontinuation.

9)

Vitamin B (B1, B2, B6) Injection 

(Becolim)

Agree to delete from the UMMC formulary. 

Company discontinuation. Availability of Vitamin B and C Injection in the UMMC formulary.

10)

Olodaterol 2.5mcg Inhalation Solution 

(Striverdi Respimat)

Agree to delete from the UMMC formulary.

Company discontinuation. Availability of Spiriva Respimat and Spiolto Respimat in the UMMC formulary.

11)

Oxybutinin 5mg Tablet

(Voxytane)

Agree to delete from the UMMC formulary.

Company discontinuation and was agreed by Peadiatric Surgery Team.

12)

Dulaglutide 0.75mg Injection

Dulaglutide 1.5mg Injection

(Trulicity)

Rejected as Special Formulary.

Dulaglutide’s Cardiovascular Outcome Trial (CVOT) published: Dulaglutide reduced cardiovascular outcomes in patients with or without previous cardiovascular disease. 

Costs more than Liraglutide 1.2mg once daily (with CVOT) and Exenatide 2mg once weekly.



Disclaimer: 

For new drug request, physical stock availability will depend on procurement processes. 

Tender items will take about 3-6 months, non tender items will take about 1-3 months. 

Online formulary will be updated once physical stock is available or has depleted in UMMC Pharmacy.

D&T Subcommittee Meeting Bil. 01/2019

posted Apr 15, 2019, 11:48 PM by Chong Ching Wern   [ updated Apr 15, 2019, 11:48 PM ]


No.

Drug Name

Decision

1)

Rufinamide 200mg Tablet

(Inovelon)

Agreed to accept as Special Formulary (upon request).

2)

Yellow Fever Vaccine Injection

(Stamaril)

Agree to accept as Special Formulary (non-claimable).

3)

Dapagliflozin 10mg Tablet

(Forxiga)

Rejected to add Cardiologists as prescriber, to maintain current restriction.

4)

Baricitinib 4mg Tablet

(Olumiant)

Rejected as Special Formulary.

Availability of Tofacitinib 5mg Tablet in the UMMC formulary.

Suggest to apply to use using BUK on named patient basis.

5)

Esomeprazole 20mg MUPS Tablet

Esomeprazole 40mg MUPS Tablet

Multiple Unit Pellet System

(Nexium / Axiago)

Agree to accept as Standard Formulary to replace Omeprazole 2mg/mL Syrup.

6)

Aripiprazole 400mg Prolonged Release Injection

(Abilify Maintena)

Agree to accept as Special Formulary.

7)

Liothyronine 100mcg Injection

Agree to delete from the UMMC formulary.

Availability of Levothyroxine 200mcg Injection in the UMMC formulary.

8)

Polymixin B Neomycin Hydrocortisone Ear Drops

(Pocin)

Agree to delete from the UMMC formulary.

Ototoxicity due to Neomycin component and removal from APPL contract list.

9)

Varenicline 1mg Tablet

(Champix)

Agree to delete from the UMMC formulary.

Closure of Smoking Cessation Clinic, no prescriptions seen since 2016, slow movement and easily available in community pharmacies.

10)

Varenicline 0.5mg Tablets x 11

Varenicline 1mg Tablets x 14

(Champix Starter Pack)

Agree to delete from the UMMC formulary.

Closure of Smoking Cessation Clinic, no prescriptions seen since 2016, slow movement and easily available in community pharmacies.

11)

Clodronate Sodium 800mg Tablet

(Bonefos)

Agree to delete from the UMMC formulary.

Company discontinuation.

12)

Isotretinoin 10mg Capsule

(Roaccutane)

Rejected to delete from the UMMC formulary, to maintain current restriction.

13)

Isotretinoin 20mg Capsule

(Roaccutane)

Rejected to delete from the UMMC formulary, to maintain current restriction.

14)

Dulaglutide 0.75mg Injection

Dulaglutide 1.5mg Injection

(Trulicity)

Pending press release on cardiovascular safety outcome trial in June 2019.

Costs more than existing agents available in the UMMC formulary.

Suggest to review pricing.



Disclaimer:

For new drug request, physical stock availability will depend on procurement processes.

Tender items will take about 3-6 months, non tender items will take about 1-3 months.

Online formulary will be updated once physical stock is available or has depleted in UMMC Pharmacy.

D&T Subcommittee Meeting 10 December 2018

posted Jan 21, 2019, 6:55 PM by Chong Ching Wern   [ updated Jan 21, 2019, 6:55 PM ]


No.
 Drug Name
 Decision
 
 1)
Posaconazole 100mg M/R Tablet
(Noxafil)
Agreed to accept as Special Formulary to replace Posaconazole 40mg/mL Suspension.
 
 
 2)
Tenofovir Disoproxil Fumarate 300mg Emtricitabine 200mg Efavirenz 600mg Tablet
Agree to accept as Standard Formulary as an add-on to currently available antiretroviral agents in the UMMC's Formulary.
 
 3)
Brinzolamide 1% Brimonidine 0.2% Ophthalmic Suspension
(Simbrinza)
Agree to accept as Special Formulary.
 
 4)
Pimecrolimus 1% Cream
(Elidel)
Agree to accept as Special Formulary for mild to moderate atopic dermatitis (Dermatologists only).
 
 5)
Aripiprazole 400mg Prolonged Release Injection
(Abilify Maintena)
 
Rejected as Special Formulary.

 
 6)
Citrate Solution (5L)
(Prismocitrate 18/0)
Agree to accept as Standard Formulary.
 
 7)
Rilpivirine 25mg Tablet 
(Edurant)
Rejected as Special Formulary.
Costs more than existing agents available in the UMMC's Formulary. 
Available in UMSC for purchase. 
 
 8)
Liraglutide 1.8mg Injection 
(Victoza)
Rejected to add Cardiologists as prescribers, to maintain current restriction.
There are other existing oral anti-diabetes agents that Cardiologists can prescribe at a lower cost in the UMMC's Formulary.
 
 9)
 Alteplase 50mg Injection
 
Acknowledged on the agreement of Pharmacy Department  to increase to 30 sets per year (effective October 2018).
 
10)
Nicotine 10mg Patch
(Nicorette)
 
Agree to delete from the UMMC's formulary.
Slow moving and stocks expired.
 
11)
 Nicotine 15mg Patch
(Nicorette)
 
Agree to delete from the UMMC's formulary. 
Slow moving and stocks expired.
 
12)
 Nicotine 25mg Patch
(Nicorette)
 
Agree to delete from the UMMC's formulary. 
Slow moving and stocks expired.
 
13)
Afatinib 50mg Tablet
(Giotrif)
 
Agree to delete from the UMMC's formulary.
Company discontinuation. 
Availability of 30mg and 40mg preparations in the UMMC's Formulary.
 
14)
Dronedarone 400mg Tablet
(Multaq)
 
Agree to delete from the UMMC's formulary.
Company discontinuation.
 
15)
Efavirenz 200mg Tablet
(Stocrin)
Agree to delete from the UMMC's formulary.
Company discontinuation.
Availability of Efavirenz 600mg Tablet preparation in the UMMC's Formulary.
 
16)
Vardenafil 10mg Tablet
(Levitra)
 
Agree to delete from the UMMC's formulary.
Availability of alternatives in the UMMC's Formulary.
 
17)
Vardenafil 20mg Tablet 
(Levitra)
 
Agree to delete from the UMMC's formulary. 
Availability of alternatives in the UMMC's Formulary.
 
18)
Strontium Ranelate 2gm Powder
(Protaxos)
 
Agree to delete from the UMMC's formulary. 
Company discontinuation.
 
19)
Buprenorphine 10mg Patch
(Sovenor)
 
Agree to delete from the UMMC's formulary. 
Company discontinuation. 
Availability of Buprenorphine 5mg Patch preparation in the UMMC's Formulary.
 
20)
Lamivudine 100mg Tablet
(Zeffix)
 
Agree to delete from the UMMC's formulary.
Slow moving and as per agreement by Gastroenterology Team.
Availability of alternatives in the UMMC's Formulary.
 
21)
Adefovir 10mg Tablet
(Hepsera)
 
Agree to delete from the UMMC's formulary. 
Slow moving and as per agreement by Gastroenterology Team. 
Availability of alternatives in the UMMC's Formulary.
 
22)
Isotretinoin 10mg Capsule
(Roaccutane)
 
Pharmacy to obtain consent from Dermatology Team before deleting from Special Formulary, to maintain current restriction.
 
23)
Isotretinoin 20mg Capsule
(Roaccutane)
 
Pharmacy to obtain consent from Dermatology Team before deleting from Special Formulary, to maintain current restriction.
 
24)
Interferon Alfa-2B 18 million units Injection
(Intron A)
 
Agree to delete from the UMMC's formulary. 
Company discontinuation.
 
25)
Interferon Alfa-2B 30 million units Injection
(Intron A) 
 
Agree to delete from the UMMC's formulary. 
Company discontinuation.
 
26)
Abciximab 10mg/mL Injection
(Repro)
 
Agree to delete from the UMMC's formulary.
Company discontinuation.
 
27)
Posaconazole 40mg/mL Suspension
(Noxafil)
 
Agree to delete from the UMMC's formulary.  
Replaced by Posaconazole M/R Tablet.


Disclaimer: 
For new drug request, physical stock availability will depend on procurement processes. 
Tender items will take about 3-6 months, non tender items will take about 1-3 months. 
Online formulary will be updated once physical stock is available or has depleted in UMMC Pharmacy.

D&T Subcommittee Meeting 24 September 2018

posted Oct 15, 2018, 12:58 AM by Chong Ching Wern   [ updated Oct 15, 2018, 1:14 AM ]


 No.
 Drug Name
 Decision
 
 1)
 Oxycodone Hydrochloride 10mg/mL Injection
 (Oxynorm)
 Rejected as UMMC Formulary. 
 Available in UMSC for purchase.
 
 2)
 Alirocumab 75mg Injection
 Alirocumab 150mg Injection 
 (Praluent)
 Rejected as Special Formulary.
 Apply for use via BUK form on named patient basis.
 
 3)
 Liraglutide 1.8mg Injection 
 (Victoza)
 To be discussed again in next D&T Meeting in December    2018.
 
 4)
 Linagliptin 5mg Tablet 
 (Trajenta)
 Agreed to to switch Sitagliptin (350 subsidy cards) to   Linagliptin (350 subsidy cards) in Outpatient Pharmacy in   the next tender due in 2020.
 
 5)
 Macitentan 10mg Tablet 
 (Opsumit)
 
 Agreed to accept Macitentan as Special Formulary to   replace Bosentan 125mg Tablet (Tracleer).
 
 6)
 Glycopyrronium 50mcg Inhalation Capsule
 (Seebri Breezhaler)
 Rejected as Special Formulary.
 Available in UMSC for purchase.
 
 7)
 Celecoxib 200mg Capsule
 (Celebrex)
 Agreed to supply Celecoxib to Orthopedics in-patients for   acute pain management of fractures pre-operation and
 post-operation up to maximum of 20 capsules in total. 
 
 8)
 Dapagliflozin 10mg Tablet
 (Forxiga)
 Rejected to add new prescribers, to maintain current   restriction.
 
 9)
 Ketosteril Tablet
 
 No new patients with immediate effect.
 Pharmacy to continue supplying for existing 164 AP patients   until 31 December 2019.
 All patients to pay full cost and not claimable effective 1   January 2020.
 
10)
 Olodaterol 2.5mcg Inhalation Solution
 (Striverdi Respimat)
 
 Agreed to change from UMMC Formulary to Special   Formulary.
 
11)
 Tacrolimus 0.5mg Capsule
 Tacrolimus 1mg Capsule
 (Prograf)
 
 Rejected to add 20 subsidy cards for the indication of Lupus   Nephritis, to maintain current restriction.
 
12)
 Vildagliptin 50mg Tablet
 (Galvus)
 
 Deleted.
 
13)
 Vildagliptin 50mg Metformin 850mg Tablet
 Vildagliptin 50mg Metformin 1000mg Tablet
 (GalvusMet)
 
 Deleted.
 
14)
 Sitagliptin 100mg Tablet
 (Januvia)
 
 Deleted.
 To be replaced by Linagliptin in the next tender once current   tender ends in year 2020.
 
15)
 Sitagliptin 50mg Metformin 850mg Tablet
 Sitagliptin 50mg Metformin 1000mg Tablet
 (JanuMet)
 Deleted.
 
16)
 Bosentan 125mg Tablet
 (Tracleer)
 
 Deleted.
 
17)
 Sertraline 50mg Tablet
 (Zoloft)
 
 Deleted.
 
18)
 Alendronate 70mg Cholecalciferol 5600iu Tablet   (Fosamax Plus)
 
 Deleted.
 
19)
 Etoposide 50mg Capsule
 
 Deleted.
 
20)
 Granisetron 1mg Tablet
 
 Deleted.
 
21)
 Pilocarpine 2% Eye Drop
 Pilocarpine 4% Eye Drop
 
 Deleted.

Disclaimer: 
For new drug request, physical stock availability will depend on procurement processes. 
Tender items will take about 3-6 months, non tender items will take about 1-3 months. 
Online formulary will be updated once physical stock is available or has depleted in UMMC Pharmacy.

D&T Subcommittee Meeting 4 June 2018

posted Jun 24, 2018, 6:14 PM by Chong Ching Wern   [ updated Jun 24, 2018, 6:15 PM ]

 
 No.
 Drug Name
 Decision
 
 1)
 Fluticasone Propionate 125mcg Formoterol 5mcg
 Inhaler
 Fluticasone Propionate 250mcg Formoterol 10mcg
 Inhaler
 (Flutiform)
 Accepted only one strength (Fluticasone Propionate 125mcg
 Formoterol 5mcg Inhaler) as Special Formulary.
 
 2)
 Benzydamine Hydrochloride 0.3% Spray 
 (Difflam Forte Throat Spray)
 Rejected to add new prescribers, to maintain current
 restrictions.
 
 3)
 Ibuprofen 20mg/mL Oral Suspension
 Accepted as Standard Formulary for paediatrics with Patent 
 Ductus Arteriosus (PDA) only.
 
 4)
 Desmopressin 200mcg Tablet 
 (Minirin)
 Agreed to add Paediatric Nephrologist as prescriber for
 paediatrics with Primary Nocturnal Enuresis (PNE) only.
 
 5)
 Dinoprostone 10mg Vaginal Delivery System
 (Cervidil)
 
 Rejected.
 
 6)
 Rituximab 1400mg/11.7mL Solution for SC
 Injection
 (MabThera SC)
 Accepted as Special Formulary (upon request).
 
 7)
 Fentanyl 100mcg Sublingual Tablet
 Fentanyl 200mcg Sublingual Tablet
 Fentanyl 400mcg Sublingual Tablet
 (Abstral)
 
 Accepted as Special Formulary (200 and 400mcg
 upon request).
 
 8)
 Dolutegravir 50mg Tablet 
 (Tivicay)
 Agreed to have 40 subsidy cards.
 Changed Post Exposure Prophylaxis (PEP) regimen to
 Tenofovir / Emtricitabine + Dolutegravir.
 
 9)
 Lopinavir 200mg Ritonavir 50mg Tablet 
 (Kaletra)
 
 Agreed to change 20 Kaletra's subsidy cards to 20
 Dolutegravir's subsidy cards.
 Total Kaletra's subsidy cards will now be 130. (Refer Item 8)
 
10)
 Raltegravir 400mg Tablet 
 (Tivicay)
 
 Agreed to replace all 20 Raltegravir's subsidy cards with 20
 Dolutegravir's subsidy cards. (Refer Item 8)
 
11)
 Beclometasone 100mcg Formoterol 6mcg Inhaler
 (Foster)
 
 Deleted.
 
12)
 Nimodipine 30mg Tablet 
 (Nimotop)
 
 Deleted.
 
13)
 Etoricoxib 60mg Tablet 
 (Arcoxia)
 
 Deleted.
 
14)
 Esomeprazole 40mg Injection
 (Nexium)
 
 Deleted.
 
15)
 Lercanidipine 10mg Tablet
 (Zanidip)  
 
 Deleted.
 
16)
 Asenapine 5mg Dispersible Wafer
 (Saphris)
 
 Deleted.
 
17)
 Pentosan Polysulfate 100mg Capsule
 (Elmiron)
 
 Deleted.
 
18)
 Amoxicillin 1000mg Tablet 
 (Ospamox)
 
 Deleted.
 
19)
 Levocetirizine 5mg Tablet
 (Xyzal)
 
 Deleted.
 
20)
 Fluconazole 150mg Capsule
 (Diflucan)
 
 Deleted.
 
21)
 Carboxymethycellulose 0.5% Eye Drop
 (Optive Advanced)
 
 Deleted.
 
22)
 Ethinylestradiol 20mcg Desogestrel 150mcg Tablet
 (Mercilon)
 
 Deleted.
 
23)
 Chlorhexidine 0.015% Cetrimide 0.15% Irrigation
 Solution (30mL)
 
 Deleted.
 
24)
 Ambroxol 30mg Tablet
 (Mucosolvan)
 
 Deleted.
 
25)
 Paracetamol 500mg Injection
 (Paracetamol Kabi)
 
 Deleted.

Disclaimer: 
For new drug request, physical stock availability will depend on procurement processes. 
Tender items will take about 3-6 months, non tender items will take about 1-3 months. 
Online formulary will be updated once physical stock is available or has depleted in UMMC Pharmacy.

1-10 of 11